Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Immunohistochemical detection of prostate specific antigen (PSA) is widely used to identify metastatic prostatic adenocarcinoma. However, PSA may not be expressed in some poorly differentiated prostatic carcinomas and its immunoreact...
Main Authors: | Parwani Anil V, Dhir Rajiv, Yin Ming |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Diagnostic Pathology |
Online Access: | http://www.diagnosticpathology.org/content/2/1/41 |
Similar Items
-
Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas
by: Gowri Garudadri, et al.
Published: (2020-01-01) -
Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
by: Parwani Anil V, et al.
Published: (2011-07-01) -
Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01) -
Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
by: Törnblom, M, et al.
Published: (2001) -
Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
by: Sävblom, C, et al.
Published: (2009)